Kathryn Penkus Corzo
Director · Marker Therapeutics, Inc.
Individual
- 2025
- Nov 4, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Kathryn Penkus Corzo. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- New Enterprise Associates 16, L.P. - $1.77M in MRKR purchases and sales on record
- Steve Elms - $35K in MRKR purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kathryn Penkus Corzo?
Kathryn Penkus Corzo is a corporate insider, tracked as Director of Marker Therapeutics, Inc. (MRKR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kathryn Penkus Corzo last file a Form 4?
The only primary Form 4 on record is dated 4 November 2025.